RELAPSE RATE OF PATIENTS AFTER HEALING OF ESOPHAGITIS - A PROSPECTIVE-STUDY OF ALGINATE AS SELF-CARE TREATMENT FOR 6 MONTHS

Authors
POYNARD T ABADIA R ABBAS A ABENSUR R ALLE JP ALLEMOZ D AMAR I AMERIEN G AMSELLEM A ARRAMONTUCOO D ARZUL C AUBERT H AUCOMTE A AUDEGON G AUFFRET Y AZZI A BADETTI J BAGNOULS G BANDU M BASIN N BERCK C BECQWORT JP BEGUE JY BENGUALID J BENHAIM S BERAUD G BILLARD JL BLIME JP BOEHM C BONIN N BOTTOS JP BOUCHER AM BOULENGER F BOUQUET JP BOYER JD BRAJER S BREBAN P BREDOUX P BRODSCHII F BURGUIERE P BUTEL J CALVET B CAMBRAY S CANARD JM CAUSSE JL CAZALS JB CERF G CHANTELOUP JM CHAPALAIN JC CHARBIT M CHAUVEINC L CHIESA A COLONNA P COLSON M COMUCE C CONGRAD P CONSIGNY P COOMANS D COTINAT M COTTEN JC COUDERT P COULANJON G COULOM P COURTIAL P CUTURELLO L DANTIN B DECROIX B DELETTE O DELTOMBE B DIACONO M DIAZ J DUREAU A DUDICOURT JC DUPERIE J DUPINNIZARD B DUPONT T DURY P EDOUARD R ELHAIK E ELOUARDBLANC L ESTABLE P FIGAROLBOUTIN MF FORTAS L FORTIER B FOUCARD M FOURGUETTE E FEMOND L GABRIELE R GABRIELLINI F GALTIE G GAUSSEN JM GAUTIER JM GOBERT F GOLDFAIN D GOMEZ H GRANGE M GRUNBERG B HALPERIN S HERBET T HILPERT G HOUDEE G JACQUES JP JONAS C JULIEN PE JULIEN H JUTEL P KAFFY L KALT P KARSENTY C KHERROUBI H KIRIAKOS A KOLOPP JL LAMIRAUD B LAPLANE B LAREDO JC LARRUE P LAUGROS A LAURENT P LEBAYON A LEBIHAN P LECOUTEULX C LETEXIER A LETORTU R LECLERC P LEDUC JL LEFEVRE R LELONG P LEMARCHAND N LEMEE P ANTOINE L LEURENT B LHERMIE M LOISON P LOMBARDO G LOMBART J LOTH F LOUBIERE M LOYER R LUCIANI F LUNAUD B MACHEREY D MAGEN M MAGOIS JY MAHE M MAIRE P MAJEAU JM MANIERE A MARCHETTI B MARGULIES A MAROIS F GEORGE M MASBOU P MASSABIE B MATTEI A MERLIN P MESSERSCHMITT C MIR WS MONGES B MOURRUT C NAVARRO P NAYRAC A NEUMEIER M NGUYEN PT NIZARD G NOIZET JM NOUN K NURY B OLLIVIER B PARIENTE E PARIS Y PARMENTIER T PAROIS L PAUTRAT JM PAUWELS B PECRIAUX O PELLAT B PEROUA JJ PERRIGUEY M PFLUMIO F PICARD J PLANTE M PLIHON G POMMELET P PORTEFAIX JP QUIVIGER JF RAIMBERT P RAPOPORT G RAYNAL JN RESENSBERG M REIG JJ RENAULT G REVOL C RICHARD M RICHARD P RIERA JC RION JL ROBLIN X ROGIER P ROTENBERG A ROUSSY P ROUX M RUMEAU JM SALVATORI G SANCHEZ JY SAURFELT MM SCHLOSSERG P SCHMITZ D SCOTTO JM SENG G SERVENT L SIMON JF SOUILE JM SPREUX T TAOUBI N TESTE Y TRAISSAC JP TUBIANA B TUBIANA GE VANDRO P VEBER P VEDEL JP VENOT J VERMEULEN L VERNEAU A VERNISSE B VEYRES B VIAUD S VIELH J VILLAND J VILLARD J VITAUX J WALLEZ JY WANTIER M WEBER JE ZARKA A
Citation
T. Poynard et al., RELAPSE RATE OF PATIENTS AFTER HEALING OF ESOPHAGITIS - A PROSPECTIVE-STUDY OF ALGINATE AS SELF-CARE TREATMENT FOR 6 MONTHS, Alimentary pharmacology & therapeutics, 7(4), 1993, pp. 385-392
Citations number
9
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
02692813
Volume
7
Issue
4
Year of publication
1993
Pages
385 - 392
Database
ISI
SICI code
0269-2813(1993)7:4<385:RROPAH>2.0.ZU;2-J
Abstract
In order to estimate the rate of symptomatic relapse and to identify f actors associated with this relapse, 1030 patients were included in a multicentre study. All patients included had clinically and endoscopic ally healed oesophagitis (grade I (erosion, 57%), grade II (confluent erosion, 33%) or grade III (circular erosion, 9%)) after treatment wit h an H-2-blocker or omeprazole. Patients were given conservative advic e and were told to take sodium alginate only in response to pain. Rela pse was defined as pain justifying more than eight sodium alginate sac hets over 48 hours or treatment with another drug, or the need for a n ew endoscopy. Forty risk factors were recorded initially and patients were seen every 2 months; they filled out diary-cards describing sympt oms and drug consumption. Data were available for 883 patients during follow up. The cumulative percentage of patients without relapse at 6 months estimated by Kaplan Meier method was 76 +/- 2 % (mean +/- S.E.M .). Among these patients without relapse, 95% took less than two sache ts per day. Only two factors were identified as associated with relaps e-the grade of oesophagitis (P < 0.007), and the occurrence of stress during follow-up (P < 0.05). The percentage of patients free from rela pse at six months was 85 +/- 2% in patients with grade I oesophagitis, 69 +/- 3% in patients with grade II, and 56 +/- 6% in patients with g rade III oesophagitis (P < 0.0001).